
Sign up to save your podcasts
Or


VSD's Editor-in-Chief Sharon Spielman interviews Bill Rayner and Alex Drew of Efferent Labs about the Cytocom platform — an implantable biosensor that combines living cells, smart materials, miniaturized photonics, and AI analytics to deliver real-time in vivo cellular data.
By Endeavor Business MediaVSD's Editor-in-Chief Sharon Spielman interviews Bill Rayner and Alex Drew of Efferent Labs about the Cytocom platform — an implantable biosensor that combines living cells, smart materials, miniaturized photonics, and AI analytics to deliver real-time in vivo cellular data.